Sornasse T, Larenas P V, Davis K A, de Vries J E, Yssel H
Department of Human Immunology, DNAX Research Institute, Palo Alto, California 94304, USA.
J Exp Med. 1996 Aug 1;184(2):473-83. doi: 10.1084/jem.184.2.473.
The development of CD4+ T helper (Th) type 1 and 2 cells is essential for the eradication of pathogens, but can also be responsible for various pathological disorders. Therefore, modulation of Th cell differentiation may have clinical utility in the treatment of human disease. Here, we show that interleukin (IL) 12 and IL-4 directly induce human neonatal CD4- T cells, activated via CD3 and CD28, to differentiate into Th1 and Th2 subsets. In contrast, IL-13, which shares many biological activities with IL-4, failed to induce T cell differentiation, consistent with the observation that human T cells do not express IL-13 receptors. Both the IL-12-induced Th1 subset and the IL-4-induced Th2 subset produce large quantities of IL-10, confirming that human IL-10 is not a typical human Th2 cytokine. Interestingly, IL-4-driven Th2 cell differentiation was completely prevented by an IL-4 mutant protein (IL-4.Y124D), indicating that this molecule acts as a strong IL-4 receptor antagonist. Analysis of single T cells producing interferon gamma or IL-4 revealed that induction of Th1 cell differentiation occurred rapidly and required only 4 d of priming of the neonatal CD4+ T cells in the presence of IL-12. The IL-12-induced Th1 cell phenotype was stable and was not significantly affected when repeatedly stimulated in the presence of recombinant IL-4. In contrast, the differentiation of Th2 cells occurred slowly and required not only 6 d of priming, but also additional restimulation of the primed CD4+ T cells in the presence of IL-4. Moreover, IL-4-induced Th2 cell phenotypes were not stable and could rapidly be reverted into a population predominantly containing Th0 and Th1 cells, after a single restimulation in the presence of IL-12. The observed differences in stability of IL-12- and IL-4-induced human Th1 and Th2 subsets, respectively, may have implications for cytokine-based therapies of chronic disease.
CD4+辅助性T(Th)1型和2型细胞的发育对于根除病原体至关重要,但也可能导致各种病理紊乱。因此,调节Th细胞分化可能在人类疾病治疗中具有临床应用价值。在此,我们表明白细胞介素(IL)-12和IL-4可直接诱导经由CD3和CD28激活的人类新生儿CD4+T细胞分化为Th1和Th2亚群。相比之下,与IL-4具有许多生物学活性相同的IL-13未能诱导T细胞分化,这与人类T细胞不表达IL-13受体的观察结果一致。IL-12诱导的Th1亚群和IL-4诱导的Th2亚群均产生大量IL-10,证实人类IL-10并非典型的人类Th2细胞因子。有趣的是,一种IL-4突变蛋白(IL-4.Y124D)完全阻止了IL-4驱动的Th2细胞分化,表明该分子可作为一种强效的IL-4受体拮抗剂。对产生干扰素γ或IL-4的单个T细胞的分析显示,Th1细胞分化的诱导迅速发生,在IL-12存在的情况下,仅需对新生儿CD4+T细胞进行4天的致敏。IL-12诱导的Th1细胞表型稳定,在重组IL-4存在的情况下反复刺激时不受显著影响。相比之下,Th2细胞的分化发生缓慢,不仅需要6天的致敏,还需要在IL-4存在的情况下对致敏的CD4+T细胞进行额外的再刺激。此外,IL-4诱导产生的Th2细胞表型不稳定,在IL-12存在的情况下进行单次再刺激后,可迅速转变为主要包含Th0和Th1细胞的群体。分别观察到的IL-12和IL-4诱导的人类Th1和Th2亚群稳定性的差异,可能对基于细胞因子的慢性疾病治疗具有启示意义。